Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 3 institutions in 2 countries.
Panthakarn RangsinthDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0001-7255-9012
Nattaporn PattarachotanantDepartment of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-2710-4980
Wen WangDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-7060-0779
Polly Ho-Ting ShiuDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
Chengwen ZhengDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0002-2633-643X
Renkai LiDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.
Tewin TencomnaoDepartment of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0003-4177-2165
Siriporn ChuchawankulDepartment of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-7627-0408
Anchalee PrasansuklabCollege of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0001-8884-3077
Timothy Man-Yau CheungTian Ran Healthcare Limited, Hong Kong SAR, China.
Jingjing LiDepartment of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China.
George Pak-Heng LeungDepartment of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-3529-9367
University of Hong Kong · HKChulalongkorn University · THHong Kong Polytechnic University · HK
Funding
Partnership Research Program of the Innovation and Technology Fund PRP/100/20FX
6 · The paper itself
Abstract
The pharmacological activity and medicinal significance of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Neuroprotective Effects of Polysaccharides and Gallic Acid from · full record | OpenQuestion